Wound Care

---

 BIOPTRON® Hyperlight increases the production of endogenous collagen, giving to the connective tissues the structure and stability necessary for elasticity and skin strength. BIOPTRON® Hyperlight therapy fosters the recovery of tissues to a healthy and functional state.

(De Melo et al., 2016)

BIOPTRON® Hyperlight increases the blood flow in irradiated capillaries, boosting the oxygen and nutrients supply, as well as the uptake of nocive substances produced by damaged cells. BIOPTRON® Hyperlight therapy provides to the new-formed cells all they need to favour healthy tissue regeneration.

(Samoilova et al., 2008)

BIOPTRON® Hyperlight decreases the production of pro-inflammatory cytokines, such as TNF-α, and increases anti-inflammatory cytokines, such as TGF –β and IL-10, in the irradiated region, reducing locally the inflammation of affected epithelium.

(Falus et al 2011, Zhevago 2006)

 onstant and intolerable pain is disabling and devastating in patients with chronic wounds. Pain impairs wound healing and slows down patient recovery. BIOPTRON® Hyperlight Therapy reduces pain by stimulating the production of nitric oxide, which decreases the over-stimulation of somatic peripheral nerves and increases vasodilatation, diminishing in parallel the ischemic pain.

(Gaspariyan et al., 2005; Samoilova et al., 2008)

Chronic wounds are very often characterized by poor and deficient blood supply, which could slow down and delay the recovery. BIOPTRON® Hyperlight promotes angiogenesis by developing new capillaries. The increased number and length of capillaries contribute to healthy tissue regeneration and shorter recovery time.

(Gasparyan et al., 2005)

Infections are a major risk factor in chronic open wounds that negatively affect wound management. BIOPTRON® Hyperlight contains blue light, which is very well known for its intrinsic antimicrobial effect, without the addition of exogenous photosensitizers. The regular use of BIOPTRON® Hyperlight prevents the development of bacterial infection.

(Opel et al, 2015)

In parallel, BIOPTRON® Hyperlight Therapy increases IL-6, which increases the production of IgM antibodies by B lymphocytes, providing defence against blood-borne pathogens.

(Fenyo et al., 1992)

The secretion of IFN-γ is as well promoted, reinforcing the microbicidal and antiviral action of natural killer cells.

(Zhevago, 2006)